David Einhorn · Q2 2025
Greenlight Capital
Portfolio at the end of Q2 2025, from the 13F filed August 14, 2025. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Green Brick Partners GRBK · history | 25.6% | Q2 2013 or earlier | No change |
| Fluor FLR · history | 8.4% | Q2 2025 | Buy |
| Core Natural Resources CNR · history | 6.5% | Q1 2025 | Reduce 2% |
| Brighthouse Financial BHF · history | 6.4% | Q3 2017 | Reduce 1% |
| Kyndryl KD · history | 6.0% | Q4 2021 | Reduce 20% |
| PENN Entertainment PENN · history | 5.8% | Q1 2024 | Add 20% |
| CNH Industrial CNH · history | 4.4% | Q3 2024 | Reduce 3% |
| Graphic Packaging GPK · history | 4.3% | Q2 2021 | Add 349% |
| DHT DHT · history | 3.5% | Q3 2023 | Add 15% |
| Teck Resources TECK · history | 3.5% | Q2 2020 | No change |
| HP HPQ · history | 3.2% | Q1 2024 | No change |
| Teva TEVA · history | 2.7% | Q4 2023 | Add 565% |
| Capri Holdings CPRI · history | 2.6% | Q2 2024 | No change |
| Liberty Global LBTYA · history | 2.2% | Q1 2024 | No change |
| SPDR Gold Trust GLD · fund · history | 2.2% | Q2 2020 | Reduce 6% |
| Roivant Sciences ROIV · history | 2.2% | Q1 2024 | Reduce 16% |
| Weatherford International WFRD · history | 2.1% | Q1 2022 | Add 110% |
| Centene CNC · history | 2.0% | Q4 2024 | Add 53% |
| Seadrill SDRL · history | 1.8% | Q2 2023 | No change |
| Cigna Group CI · history | 1.3% | Q2 2025 | Buy |
| Acadia Healthcare ACHC · history | 0.8% | Q4 2024 | Add 616% |
| Victoria's Secret VSCO · history | 0.7% | Q2 2025 | Buy |
| Lakefront Biotherapeutics LKFT · history | 0.6% | Q4 2021 | No change |
| Coya Therapeutics COYA · history | 0.4% | Q4 2022 | No change |
| TD Synnex SNX · history | 0.2% | Q4 2024 | Reduce 28% |
| VanEck Gold Miners ETF GDX · fund · history | 0.2% | Q1 2024 | No change |
| VanEck ETF VANECK-607 · fund · history | 0.2% | Q1 2023 | Add 29% |
| Sotera Health SHC · history | 0.1% | Q2 2025 | Buy |
| GoPro GPRO · history | 0.1% | Q1 2021 | No change |
| Peloton PTON · history | 0.1% | Q2 2024 | Reduce 96% |
| Gain Therapeutics GANX · history | 0.0% | Q1 2021 | No change |
| Nuvation Bio NUVB · history | 0.0% | Q1 2021 | No change |
| Nuvation Bio NUVB.WS · warrants · history | 0.0% | Q1 2021 | No change |
| Katapult KPLT.WS · warrants · history | 0.0% | Q2 2021 | No change |
| 34 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q1 2025, adjusted for stock splits.
Sector weighting
| Industrials | 44.1% | |
|---|---|---|
| Materials | 14.2% | |
| Financials & real estate | 9.7% | |
| Technology | 9.3% | |
| Health care | 6.9% | |
| Consumer discretionary | 6.5% | |
| Other | 2.6% | |
| Funds & ETFs | 2.5% | |
| Media & telecom | 2.2% | |
| Energy | 1.8% |
What changed from Q1 2025
- Buy Fluor FLR 8.4% of the 13F
- Buy Cigna Group CI 1.3% of the 13F
- Buy Victoria's Secret VSCO 0.7% of the 13F
- Buy Sotera Health SHC 0.1% of the 13F
- Add 20% PENN Entertainment PENN 5.2% → 5.8%
- Add 349% Graphic Packaging GPK 1.4% → 4.3%
- Add 15% DHT DHT 3.5% → 3.5%
- Add 565% Teva TEVA 0.4% → 2.7%
- Add 110% Weatherford International WFRD 1.2% → 2.1%
- Add 53% Centene CNC 1.7% → 2.0%
- Add 616% Acadia Healthcare ACHC 0.2% → 0.8%
- Add 29% VanEck ETF VANECK-607 0.2% → 0.2%
- Reduce 2% Core Natural Resources CNR 8.6% → 6.5%
- Reduce 1% Brighthouse Financial BHF 8.2% → 6.4%
- Reduce 20% Kyndryl KD 6.6% → 6.0%
- Reduce 3% CNH Industrial CNH 5.0% → 4.4%
- Reduce 6% SPDR Gold Trust GLD 2.6% → 2.2%
- Reduce 16% Roivant Sciences ROIV 2.8% → 2.2%
- Reduce 28% TD Synnex SNX 0.2% → 0.2%
- Reduce 96% Peloton PTON 1.6% → 0.1%
- Sell Viatris VTRS was 2.6%
- Sell Dollar Tree DLTR was 1.7%
- Sell Alight ALIT was 0.3%